U.S. Halts $500 Million in mRNA Vaccine Funding, Citing Risks
The United states Department of Health and Human Services plans to cancel $500 million in financial support for the development of mRNA vaccines targeting viruses such as influenza and COVID-19, a move that has sparked controversy among medical experts.
Robert F. Kennedy Jr.,the current Secretary of Health and Human Services,announced the cancellation of the project,which aimed to develop vaccines against bird flu and other viruses. The decision impacts 22 research projects involving major pharmaceutical companies, including Pfizer and Moderna.
Kennedy, known for his skepticism towards vaccines, stated that mRNA technology poses more risks than benefits for respiratory viruses. He claims these vaccines are ineffective at preventing upper respiratory infections and may even encourage viral mutation, prolonging outbreaks.
The decision has drawn sharp criticism from doctors and health professionals. Peter Lurie, a former Food and Drug Administration (FDA) official, described the termination as “turning our back on the best tools we have to fight the next outbreak.” Dr. Paul Offit, Director of the Vaccine Education Center at the Children’s Hospital of Philadelphia, emphasized the safety and importance of mRNA vaccines in preventing severe infections, including COVID-19.
Kennedy indicated the department will shift support to alternative vaccine platforms deemed “safer and more effective,” even as viruses mutate. However,Offit warned that this cancellation could leave the United States “more dangerous” when facing future pandemics,as mRNA vaccines offer a faster development cycle crucial for rapid response.
As assuming office, Kennedy has implemented several changes to the country’s public health agencies’ vaccine development and policies. In June, he dissolved 17 advisory committees on vaccination, replacing members with individuals who have questioned vaccine safety and efficacy. He also removed COVID-19 vaccines from the recommended immunization schedule for children and pregnant women,previously endorsed by the Centers for Disease Control and Prevention (CDC).
Disclaimer: This article provides information about public health policy and should not be considered medical advice.Consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Stay informed and join the conversation! Share this article with your network,leave a comment below with your thoughts,and subscribe to world-today-news.com for the latest updates on global health and policy.
